BUSINESS● LOWAug 17 · Aug 17, 2026, 4:59 AM
Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook
Seeking Alpha Tech
Plus Therapeutics reported GAAP EPS of -$1.31, missing analyst estimates by $0.45, while reaffirming its full-year outlook. This provides an update on the company's financial performance and future expectations.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowCritical minerals: why development banks are making a comeback in the sectorJeune AfriqueBUSINESS13m agoVale raised at Scotiabank after stock price correction; Southern Copper looks expensiveSeeking Alpha Tech